Comparative effectiveness research for prostate cancer radiation therapy: Current status and future directions

Xinglei Shen; Nicholas G. Zaorsky; Mark V. Mishra; Kathleen A. Foley; Terry Hyslop; Sarah Hegarty; Laura T. Pizzi; Adam P. Dicker; Timothy N. Showalter

doi:10.2217/fon.11.131

Comparative effectiveness research for prostate cancer radiation therapy: Current status and future directions

Xinglei Shen, Nicholas G. Zaorsky, Mark V. Mishra, Kathleen A. Foley, Terry Hyslop, Sarah Hegarty, Laura T. Pizzi, Adam P. Dicker, Timothy N. Showalter

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Abstract

Comparative effectiveness research aims to help clinicians, patients and policymakers make informed treatment decisions under real-world conditions. Prostate cancer patients have multiple treatment options, including active surveillance, androgen deprivation therapy, surgery and multiple modalities of radiation therapy. Technological innovations in radiation therapy for prostate cancer have been rapidly adopted into clinical practice despite relatively limited evidence for effectiveness showing the benefit for one modality over another. Comparative effectiveness research has become an essential component of prostate cancer research to help define the benefits, risks and effectiveness of the different radiation therapy modalities currently in use for prostate cancer treatment.

Original language	English (US)
Pages (from-to)	37-54
Number of pages	18
Journal	Future Oncology
Volume	8
Issue number	1
DOIs	https://doi.org/10.2217/fon.11.131
State	Published - Jan 2012

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2217/fon.11.131

Cite this

@article{4d87abe6ef344f9c8a7e5337549c0324,

title = "Comparative effectiveness research for prostate cancer radiation therapy: Current status and future directions",

abstract = "Comparative effectiveness research aims to help clinicians, patients and policymakers make informed treatment decisions under real-world conditions. Prostate cancer patients have multiple treatment options, including active surveillance, androgen deprivation therapy, surgery and multiple modalities of radiation therapy. Technological innovations in radiation therapy for prostate cancer have been rapidly adopted into clinical practice despite relatively limited evidence for effectiveness showing the benefit for one modality over another. Comparative effectiveness research has become an essential component of prostate cancer research to help define the benefits, risks and effectiveness of the different radiation therapy modalities currently in use for prostate cancer treatment.",

author = "Xinglei Shen and Zaorsky, {Nicholas G.} and Mishra, {Mark V.} and Foley, {Kathleen A.} and Terry Hyslop and Sarah Hegarty and Pizzi, {Laura T.} and Dicker, {Adam P.} and Showalter, {Timothy N.}",

year = "2012",

month = jan,

doi = "10.2217/fon.11.131",

language = "English (US)",

volume = "8",

pages = "37--54",

journal = "Future Oncology",

issn = "1479-6694",

publisher = "Future Medicine Ltd.",

number = "1",

}

TY - JOUR

T1 - Comparative effectiveness research for prostate cancer radiation therapy

T2 - Current status and future directions

AU - Shen, Xinglei

AU - Zaorsky, Nicholas G.

AU - Mishra, Mark V.

AU - Foley, Kathleen A.

AU - Hyslop, Terry

AU - Hegarty, Sarah

AU - Pizzi, Laura T.

AU - Dicker, Adam P.

AU - Showalter, Timothy N.

PY - 2012/1

Y1 - 2012/1

N2 - Comparative effectiveness research aims to help clinicians, patients and policymakers make informed treatment decisions under real-world conditions. Prostate cancer patients have multiple treatment options, including active surveillance, androgen deprivation therapy, surgery and multiple modalities of radiation therapy. Technological innovations in radiation therapy for prostate cancer have been rapidly adopted into clinical practice despite relatively limited evidence for effectiveness showing the benefit for one modality over another. Comparative effectiveness research has become an essential component of prostate cancer research to help define the benefits, risks and effectiveness of the different radiation therapy modalities currently in use for prostate cancer treatment.

AB - Comparative effectiveness research aims to help clinicians, patients and policymakers make informed treatment decisions under real-world conditions. Prostate cancer patients have multiple treatment options, including active surveillance, androgen deprivation therapy, surgery and multiple modalities of radiation therapy. Technological innovations in radiation therapy for prostate cancer have been rapidly adopted into clinical practice despite relatively limited evidence for effectiveness showing the benefit for one modality over another. Comparative effectiveness research has become an essential component of prostate cancer research to help define the benefits, risks and effectiveness of the different radiation therapy modalities currently in use for prostate cancer treatment.

UR - http://www.scopus.com/inward/record.url?scp=83655182378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83655182378&partnerID=8YFLogxK

U2 - 10.2217/fon.11.131

DO - 10.2217/fon.11.131

M3 - Review article

C2 - 22149034

AN - SCOPUS:83655182378

SN - 1479-6694

VL - 8

SP - 37

EP - 54

JO - Future Oncology

JF - Future Oncology

IS - 1

ER -

Comparative effectiveness research for prostate cancer radiation therapy: Current status and future directions

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this